Angio-Proteomie LLC

Boston, MA

UEI
RVNJD3A1BKV7
CAGE
501C9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Sole Proprietorship
SAM.gov registration date
Physical address
11 Park Dr #12-A, Boston, MA 02215, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Purchase of angio-proteomie primary human endothelial cells of varying tissue origins (brand-name only). This is a… 75N95022P00609 National Institute on Drug Abuse (NIH) $56,460
Angio-proteomie:1140043 [22-003949]GFP-human pulmonary artery endothelial cells (hpuaecs) originated from the donor… 75N95022P00274 National Institute on Drug Abuse (NIH) $50,710
Acquisition of GFP expressing pulmonary artery endothelial cells - covid-19 action 75N95022P00235 National Institute on Drug Abuse (NIH) $19,410
Drugs and biologicals HHSN301201500127PC National Eye Institute (NIH) $3,200
Blocking antibody of mouse vegfcat # MV1007M-m HHSN263200800660M Office of the Director (NIH) $434

Similar vendors

Vendor Location Primary NAICS
Stembiosys Inc. UEI QNQQJ5K2KXG9 San Antonio, TX 238990 All Other Specialty Trade Contractors
Codex Biosolutions Inc. UEI ZNUMJ4FKRC19 North Bethesda, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Fujifilm Cellular Dynamics, Inc. UEI H1LMMSH2CRJ5 — 541714 Research and Development in Biotechnology (except Nanobiotechnology)
AAT Bioquest Inc. UEI D5FRACU48P34 Pleasanton, CA 325413 In-Vitro Diagnostic Substance Manufacturing
Reprocell U.s.a., Inc. UEI F1KBMX8JQ385 Beltsville, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Angio-Proteomie LLC, registered as a sole proprietorship with minority-owned and Asian-Pacific American-owned business designations, provides primary human endothelial cells of varying tissue origins. According to its awards, it appears to specialize in supplying these cells for medical research purposes.

The recent federal contract awards for Angio-Proteomie LLC indicate that it has provided goods and services related to the purchase of endothelial cells, specifically pulmonary artery endothelial cells and GFP-expressing pulmonary artery endothelial cells, to the National Institutes of Health's National Center for Advancing Translational Sciences. These contracts were designated as COVID-19 actions, suggesting that the cells were used for research related to the coronavirus pandemic. The awards ranged in value from $19,410 to $56,460 and were completed or expected to be completed between July 2022 and October 2022. One award had a set-aside for total small businesses, while the others did not have specific set-asides. The goods provided were branded as Angio-Proteomie products, indicating the company's specialized offerings in this area.

Quick answers

Is Angio-Proteomie LLC registered in SAM.gov?

Yes. Angio-Proteomie LLC's SAM.gov registration is active through November 25, 2026.

What is Angio-Proteomie LLC's most recent federal award?

Angio-Proteomie LLC's most recent federal contract award is Purchase of angio-proteomie primary human endothelial cells of varying tissue origins (brand-name only). This is a… (75N95022P00609), from National Institute on Drug Abuse (NIH), on September 9, 2022.

On GovTribe

See Angio-Proteomie LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login